TNF-α-308 G/A polymorphism in Egyptian Budd-Chiari syndrome patients

References (6)

1. Shetty S, Ghosh K. Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis-a concise review. Thromb Res 2011; 127:505-512
2. Allen RD. Polymorphism of the human TNF-alpha promoter-random variation or functional diversity? Mol Immunol 1999; 36:1017-1027
3. Akar N, Hasipek M. Tumour Necrosis Factor-Alpha Gene Polymorphism (-308 G-A) in Turkish Pediatric Thrombosis Patients. Turk J Hematol 2002; 19:39-41
4. Fleischman AG, Aichberger KJ, Luty SB, Bumm TG, Petersen CL, Doratotaj S, Vasudevan KB, Latocha DH, Yang F, Press RD, Loriaux MM, Pahl HL, Silver RT, Agarwal A, O’Hare T, Druker BJ, Bagby GC, Deininger MW. TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms. Blood 2011; 118:6392-6398
5. Elahi MM, Asotra K, Matata BM, Mastana SS. Tumor necrosis factor alpha -308 gene locus promoter polymorphism: An analysis of association with health and disease. Biochim Biophys Acta 2009; 1792:163-172
6. Abdel Ghaffar TY, Elsayed SM, Sakr MA, Elsobky ES, Abdelhakam SM Yousuf S, Eğin Y, Akar N. Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd- Chiari syndrome patients. Turk J Hematol 2011; 28:299- 305 7. Ulu A, Elsobky E, Elsayed M, Yıldız Z, Tekin M, Akar N. Frequency of five thrombophilic polymorphisms in the Egyptian population. Turk J Hematol 2006; 23:100-103